MDLN Medline Inc.
Healthcare$36.74+0.00%OpenMarket Cap: $31.07B
As of 2026-05-26
Valuation
P/E (TTM)
30.25
PEG
—
P/B
2.69
P/S
1.07
EV/EBITDA
14.14
DCF Value
$109.27
FCF Yield
4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.0%
Operating Margin
7.0%
Net Margin
3.3%
ROE
6.9%
ROA
2.5%
ROIC
5.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $7.35B | 22.6% | $422.0M | $129.0M | $— | — |
| Q4 null | $7.79B | 24.6% | $425.0M | $180.0M | $— | — |
| FY null | $28.43B | 26.4% | $2.21B | $1.16B | $— | — |
| Q3 null | $7.12B | 23.9% | $574.0M | $322.0M | $— | — |
| Q2 null | $6.89B | 25.1% | $629.0M | $333.0M | $— | — |
| Q1 null | $6.64B | 24.8% | $591.0M | $322.0M | $— | — |
| FY null | $25.51B | 24.7% | $2.23B | $1.20B | $— | — |
| Q3 null | $6.39B | 24.8% | $574.0M | $324.0M | $— | — |
| Q2 null | $6.18B | 24.2% | $516.0M | $292.0M | $— | — |
| FY null | $23.23B | 22.5% | $1.44B | $234.0M | $— | — |
| FY null | $21.45B | 21.2% | $870.0M | $-25.0M | $— | — |